{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:45:06Z","timestamp":1769089506754,"version":"3.49.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0002811","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T16:26:00Z","timestamp":1401380760000},"page":"e2811","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study"],"prefix":"10.1371","volume":"8","clinical-trial-number":[{"clinical-trial-number":"nct01920750","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00128193","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Becky L.","family":"Rivoire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan A.","family":"Groathouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"TerLouw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapil Dev","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaman","family":"Ranjit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishwa Raj","family":"Sapkota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saraswoti","family":"Khadge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chatra B.","family":"Kunwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murdo","family":"Macdonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hawksworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min B.","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deanna A.","family":"Hagge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Tibbals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tina","family":"Dube","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dewei","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamodikoe","family":"Makhene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Sizemore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"key":"ref1","first-page":"1","article-title":"WHO Expert Committee on Leprosy","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref2","first-page":"108","article-title":"The tuberculin skin test","volume":"125","author":"DE Snider Jr","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"RE Huebner","year":"1993","journal-title":"Clin Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0140-6736(92)91056-E","article-title":"Immunoprophylactic trial with combined Mycobacterium leprae\/BCG vaccine against leprosy: preliminary results","volume":"339","author":"J Convit","year":"1992","journal-title":"Lancet"},{"key":"ref5","first-page":"7","article-title":"Vaccination trials against leprosy: a meeting of the epidemiology subgroup of Scientific Working Group on the Immunology of Leprosy, Geneva, 11\u201313 February, 1985","volume":"85","year":"1982","journal-title":"WHO Document TDR\/IMMLEP\/EDP"},{"key":"ref6","first-page":"218","article-title":"Comparison of reactions to human and armadillo lepromins in leprosy","volume":"43","author":"WM Meyers","year":"1975","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref7","first-page":"226","article-title":"Comparison in leprosy patients of Fernandex and Mitsuda reactions using human and armadillo antigens. A double-blind study","volume":"43","author":"JW Millar","year":"1975","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref8","unstructured":"FDA (2011) Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General. 21 CFR 210"},{"key":"ref9","unstructured":"FDA (2011) Current Good Manufacturing Practice for Finished Pharmaceuticals. 21 CFR 211."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e2791","DOI":"10.1371\/journal.pntd.0002791","article-title":"The Challenge of Producing Skin Test Antigens with Minimal Resources Suitable for Human Application against a Neglected Tropical Disease; Leprosy","author":"BL Rivoire","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref11","first-page":"501","article-title":"Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals","volume":"44","author":"AH Smelt","year":"1981","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0962-8479(96)90127-6","article-title":"Guidelines for conducting tuberculin skin test surveys in high prevalence countries","volume":"77","author":"T Arnadottir","year":"1996","journal-title":"Tuber Lung Dis"},{"key":"ref13","unstructured":"Sanofi Pasteur Limited Toronto Ontario Canada (2009) Tubersol, Tuberculin Purified Protein Derivative (Mantoux) Package Insert R19-0905 Canada."},{"key":"ref14","unstructured":"ICH (2012) MeDRA Term Selection. Technical Requirements for Registration of Pharmaceuticals for Human Use. Points to Consider 4.3"},{"key":"ref15","unstructured":"FDA (2011) Investigational New Drug Application; Responsibilities of Sponsors and Investigators. 21 CFR 312 Subpart D."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","article-title":"Leprosy","volume":"363","author":"WJ Britton","year":"2004","journal-title":"Lancet"},{"key":"ref17","first-page":"IX, X, 1","article-title":"Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006\u20132010. Operational guidelines","volume":"77","journal-title":"Lepr Rev"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00000441-200101000-00008","article-title":"Nontuberculous mycobacteria","volume":"321","author":"SM Holland","year":"2001","journal-title":"Am J Med Sci"},{"key":"ref19","first-page":"424","article-title":"Identification of environmental mycobacteria isolated from Agra, north India by conventional & molecular approaches","volume":"129","author":"D Parashar","year":"2009","journal-title":"Indian J Med Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S0950268801005532","article-title":"Environmental mycobacteria in northern Malawi: implications for the epidemiology of tuberculosis and leprosy","volume":"126","author":"PE Fine","year":"2001","journal-title":"Epidemiol Infect"},{"key":"ref21","first-page":"1","article-title":"Expert Committee on Leprosy","author":"W IMMLEP","year":"1998","journal-title":"7th Report"},{"key":"ref22","first-page":"213","article-title":"International Union Against Tuberculosis and Lung Disease, Royal Netherlands Tuberculosis Association. Revised international definitions in tuberculosis control","volume":"5","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","article-title":"Use of ranks in one-criterion variance analysis","volume":"47","author":"K W.H","year":"1952","journal-title":"Journal of the American Statistical Association"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Zhou, Obuchowski, McClish (2002) Statistical Methods in Diagnostic Medicine. Wiley.","DOI":"10.1002\/9780470317082"},{"key":"ref25","unstructured":"Organization WH (2012) Expert Committee on Leprosy, 8th Report."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1590\/abd1806-4841.20132004","article-title":"Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy","volume":"88","author":"JA Nery","year":"2013","journal-title":"An Bras Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e2440","DOI":"10.1371\/journal.pntd.0002440","article-title":"A systematic review on the epidemiological data of erythema nodosum leprosum, a type 2 leprosy reaction","volume":"7","author":"CG Voorend","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"ref28","unstructured":"FDA (2011) Investigational New Drug Application. 21 CFR 312"},{"key":"ref29","first-page":"132","article-title":"Experiences with Mycobacterium leprae soluble antigens in a leprosy endemic population","volume":"61","author":"MD Gupte","year":"1990","journal-title":"Lepr Rev"},{"key":"ref30","first-page":"481","article-title":"Fernandez and Mitsuda reactivity in guinea pigs sensitized with heat-killed Mycobacterium leprae: persistence and specificity of skin reactivity to soluble and particulate antigens","volume":"51","author":"FM Collins","year":"1983","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref31","first-page":"329","article-title":"Use of soluble antigens in leprosy epidemiology","volume":"59","author":"MD Gupte","year":"1988","journal-title":"Lepr Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1164\/ajrccm\/142.3.725","article-title":"American Thoracic Society. Diagnostic standards and classification of tuberculosis","volume":"142","journal-title":"Am Rev Respir Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1128\/CMR.19.2.338-381.2006","article-title":"The continuing challenges of leprosy","volume":"19","author":"DM Scollard","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/0003-4819-149-12-200812160-00008","article-title":"Systematic reviews of diagnostic test accuracy","volume":"149","author":"MM Leeflang","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","article-title":"Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine","volume":"39","author":"MH Zweig","year":"1993","journal-title":"Clin Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ije\/27.4.713","article-title":"Delayed-type hypersensitivity to Mycobacterium leprae soluble antigens as a test for infection with the leprosy bacillus","volume":"27","author":"JA Sterne","year":"1998","journal-title":"Int J Epidemiol"},{"key":"ref37","first-page":"1","article-title":"Report of the Eleventh and Twelfth Meetings of the Steering Committee of the Scientific Working Group on the Chemotherapy of Leprosy. Geneva. March 30\u201331 and Oct 10","volume":"82","year":"1982","journal-title":"TDR\/THELEP-SC (11\u201312)"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1517\/17530059.2013.786039","article-title":"Challenges in immunodiagnostic tests for leprosy","volume":"7","author":"A Geluk","year":"2013","journal-title":"Expert Opin Med Diagn"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/CDLI.11.5.897-900.2004","article-title":"Prospective study of serological conversion as a risk factor for development of leprosy among household contacts","volume":"11","author":"JT Douglas","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref40","first-page":"40","article-title":"Interferon-gamma responses to candidate leprosy skin-test reagents detect exposure to leprosy in an endemic population","volume":"68","author":"R Manandhar","year":"2000","journal-title":"Int J Lepr Other Mycobact Dis"},{"key":"ref41","first-page":"58","article-title":"Suppression of delayed hypersensitivity skin reactions to tuberculin by M. leprae antigens in patients with lepromatous and tuberculoid leprosy","volume":"68","author":"U Sengupta","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.tim.2012.06.002","article-title":"New pathways of protective and pathological host defense to mycobacteria","volume":"20","author":"TH Ottenhoff","year":"2012","journal-title":"Trends Microbiol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2009.12.001","article-title":"The innate immune response in leprosy","volume":"22","author":"RL Modlin","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"ref44","first-page":"181089","article-title":"Leprosy: an overview of pathophysiology","volume":"2012","author":"RM Bhat","year":"2012","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.molimm.2011.02.012","article-title":"Disruption of HLA-DR raft, deregulations of Lck-ZAP-70-Cbl-b cross-talk and miR181a towards T cell hyporesponsiveness in leprosy","volume":"48","author":"S Kumar","year":"2011","journal-title":"Mol Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/glycob\/8.2.113","article-title":"Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects","volume":"8","author":"D Chatterjee","year":"1998","journal-title":"Glycobiology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/glycob\/cws078","article-title":"Isolation of a distinct Mycobacterium tuberculosis mannose-capped lipoarabinomannan isoform responsible for recognition by CD1b-restricted T cells","volume":"22","author":"JB Torrelles","year":"2012","journal-title":"Glycobiology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4049\/jimmunol.149.2.541","article-title":"Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure","volume":"149","author":"PF Barnes","year":"1992","journal-title":"J Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1002\/pmic.200700971","article-title":"Deciphering the proteomic profile of Mycobacterium leprae cell envelope","volume":"8","author":"MA Marques","year":"2008","journal-title":"Proteomics"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.4049\/jimmunol.1103452","article-title":"New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy","volume":"188","author":"A Geluk","year":"2012","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e64215","DOI":"10.1371\/journal.pone.0064215","article-title":"Randomised clinical trial investigating the specificity of a novel skin test (C-Tb) for diagnosis of M. tuberculosis infection","volume":"8","author":"H Aggerbeck","year":"2013","journal-title":"PLoS One"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"344","DOI":"10.47276\/lr.82.4.344","article-title":"The role of Mycobacterium leprae phenolic glycolipid I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy","volume":"82","author":"JS Spencer","year":"2011","journal-title":"Lepr Rev"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2334-11-26","article-title":"Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development","volume":"11","author":"LH Sampaio","year":"2011","journal-title":"BMC Infect Dis"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.47276\/lr.75.4.376","article-title":"A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP","volume":"75","author":"FJ Moet","year":"2004","journal-title":"Lepr Rev"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/bmj.39500.885752.BE","article-title":"Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial","volume":"336","author":"FJ Moet","year":"2008","journal-title":"BMJ"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.47276\/lr.83.3.292","article-title":"Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh","volume":"83","author":"SG Feenstra","year":"2012","journal-title":"Lepr Rev"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0003065","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000}}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0002811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:54:07Z","timestamp":1689263647000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0002811"}},"subtitle":[],"editor":[{"given":"Joseph M.","family":"Vinetz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":56,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0002811","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pntd.0003065","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]}}}